vs
Side-by-side financial comparison of National CineMedia, Inc. (NCMI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $63.4M, roughly 1.3× National CineMedia, Inc.). National CineMedia, Inc. runs the higher net margin — 2.5% vs -38.1%, a 40.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 1.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -16.4%).
National CineMedia, Inc. (NCM) is an American cinema advertising company. NCM displays ads to U.S. consumers in movie theaters, online and through mobile technology. NCM presents cinema advertising across a digital in-theater network, consisting of theaters owned by AMC Theatres, Cinemark Theatres, Regal Cinemas and other regional theater circuits.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
NCMI vs PRCT — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $63.4M | $83.1M |
| Net Profit | $1.6M | $-31.6M |
| Gross Margin | 95.0% | 64.9% |
| Operating Margin | -2.8% | -4.1% |
| Net Margin | 2.5% | -38.1% |
| Revenue YoY | 1.6% | 20.2% |
| Net Profit YoY | 144.4% | -27.9% |
| EPS (diluted) | $0.02 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | — | $76.4M | ||
| Q3 25 | $63.4M | $83.3M | ||
| Q2 25 | $51.8M | $79.2M | ||
| Q1 25 | $34.9M | $69.2M | ||
| Q4 24 | $86.3M | $68.2M | ||
| Q3 24 | $62.4M | $58.4M | ||
| Q2 24 | $54.7M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | — | $-29.8M | ||
| Q3 25 | $1.6M | $-21.4M | ||
| Q2 25 | $-10.7M | $-19.6M | ||
| Q1 25 | $-30.7M | $-24.7M | ||
| Q4 24 | $24.7M | $-18.9M | ||
| Q3 24 | $-3.6M | $-21.0M | ||
| Q2 24 | $-8.7M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | 95.0% | 64.8% | ||
| Q2 25 | 93.8% | 65.4% | ||
| Q1 25 | 91.1% | 63.9% | ||
| Q4 24 | 96.4% | 64.0% | ||
| Q3 24 | 94.7% | 63.2% | ||
| Q2 24 | 93.2% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | -2.8% | -27.8% | ||
| Q2 25 | -23.2% | -28.0% | ||
| Q1 25 | -68.5% | -39.7% | ||
| Q4 24 | 23.2% | -28.9% | ||
| Q3 24 | -12.0% | -38.4% | ||
| Q2 24 | -17.0% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | — | -39.1% | ||
| Q3 25 | 2.5% | -25.7% | ||
| Q2 25 | -20.7% | -24.7% | ||
| Q1 25 | -88.0% | -35.8% | ||
| Q4 24 | 28.6% | -27.6% | ||
| Q3 24 | -5.8% | -35.9% | ||
| Q2 24 | -15.9% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | — | $-0.54 | ||
| Q3 25 | $0.02 | $-0.38 | ||
| Q2 25 | $-0.11 | $-0.35 | ||
| Q1 25 | $-0.32 | $-0.45 | ||
| Q4 24 | $0.26 | $-0.34 | ||
| Q3 24 | $-0.04 | $-0.40 | ||
| Q2 24 | $-0.09 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $29.9M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $350.5M | $347.7M |
| Total Assets | $451.9M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | $29.9M | $294.3M | ||
| Q2 25 | $37.2M | $302.7M | ||
| Q1 25 | $59.8M | $316.2M | ||
| Q4 24 | $75.2M | $333.7M | ||
| Q3 24 | $49.5M | $196.8M | ||
| Q2 24 | $53.8M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | — | $365.9M | ||
| Q3 25 | $350.5M | $380.3M | ||
| Q2 25 | $350.0M | $385.8M | ||
| Q1 25 | $370.8M | $389.2M | ||
| Q4 24 | $411.2M | $402.2M | ||
| Q3 24 | $385.5M | $241.2M | ||
| Q2 24 | $387.9M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | — | $508.1M | ||
| Q3 25 | $451.9M | $511.5M | ||
| Q2 25 | $462.0M | $513.1M | ||
| Q1 25 | $503.8M | $519.4M | ||
| Q4 24 | $568.6M | $534.0M | ||
| Q3 24 | $526.1M | $374.1M | ||
| Q2 24 | $527.2M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | — |
| Free Cash FlowOCF − Capex | $-2.0M | — |
| FCF MarginFCF / Revenue | -3.2% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | -0.63× | — |
| TTM Free Cash FlowTrailing 4 quarters | $24.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-10.3M | ||
| Q3 25 | $-1.0M | $-6.6M | ||
| Q2 25 | $-4.9M | $-15.0M | ||
| Q1 25 | $6.0M | $-17.0M | ||
| Q4 24 | $30.5M | $-32.4M | ||
| Q3 24 | $-2.0M | $-18.8M | ||
| Q2 24 | $7.7M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | $-2.0M | $-9.5M | ||
| Q2 25 | $-6.6M | $-17.8M | ||
| Q1 25 | $5.3M | $-18.8M | ||
| Q4 24 | $28.1M | $-33.6M | ||
| Q3 24 | $-2.6M | $-19.0M | ||
| Q2 24 | $6.4M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | -3.2% | -11.4% | ||
| Q2 25 | -12.7% | -22.5% | ||
| Q1 25 | 15.2% | -27.2% | ||
| Q4 24 | 32.6% | -49.2% | ||
| Q3 24 | -4.2% | -32.6% | ||
| Q2 24 | 11.7% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | 1.6% | 3.4% | ||
| Q2 25 | 3.3% | 3.5% | ||
| Q1 25 | 2.0% | 2.7% | ||
| Q4 24 | 2.8% | 1.7% | ||
| Q3 24 | 1.0% | 0.4% | ||
| Q2 24 | 2.4% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.63× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.23× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NCMI
| National Advertising Revenue | $49.9M | 79% |
| Local Advertising Revenue | $9.6M | 15% |
| Founding Member Advertising Revenue From Beverage Concessionaire Agreements | $3.9M | 6% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
